News Hub | News Direct

Healthcare

Addiction Biotech Cannabis Genetics Healthcare Medical Devices Pharmaceutical Science Veterinary
Article thumbnail News Release

Futura Medical "confident of getting FDA approval this quarter"

Futura Medical PLC

Futura Medical PLC (AIM:FUM, OTC:FAMDF) CEO James Barder speaks to Proactive following the release of full year results for 2022. Barder says that despite losses, revenues "are now rapidly coming over the horizon" and he suggests "the last two years have been very very good for us". He adds that he's "confident of getting FDA approval for MED3000 this quarter" Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 06:12 AM Eastern Daylight Time

Video
Article thumbnail News Release

Faron Pharmaceuticals moving "into next phase" with new CFO

Faron Pharmaceuticals Oy

Faron Pharmaceuticals Limited (AIM:FARN, OTC:FPHAF) chief financial officer James O'Brien speaks to Proactive on his second day in the new role. O'Brien reveals more about what he believes he can bring to Faron, highlighting his experience in the US capital markets. He adds that Faron is now moving "into [its} next phase of growth." Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 05:27 AM Eastern Daylight Time

Video
Article thumbnail News Release

MGC Pharmaceuticals' focus "will not change" despite psilocybin news

MGC Pharmaceuticals Ltd

MGC Pharmaceuticals Ltd (LSE:MXC, OTC:MGCLF, ASX:MXC) chief commercial officer Robert Clements speaks to Proactive after announcing that the company has been granted permission by the Slovenian government to conduct research into psilocybin, a naturally occurring psychedelic compound found in certain types of mushrooms. The company will work in partnership with other pharmaceutical companies to determine the best potential use for psilocybin. Clements says that "the focus of MGC will not change" despite the news, adding that it is fully committed to its current pipeline of products. Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com

April 06, 2023 05:14 AM Eastern Daylight Time

Video
Article thumbnail News Release

Xeris Biopharma enters research collaboration with Regeneron Pharmaceuticals to advance XeriJect

Xeris Biopharma Holdings

Xeris Biopharma chairman and CEO Paul Edick joins Proactive's Natalie Stoberman to share details behind its research evaluation collaboration with Regeneron Pharmaceuticals for further XeriJect development. Edick says the agreement will see Xeris using its proprietary drug-formulation platform, XeriJect, to develop ultra-highly concentrated, ready-to-use, small volume subcutaneous injections of two undisclosed monoclonal antibodies developed by Regeneron. Xeris will receive an upfront payment and potential milestone payments for preclinical achievements. Regeneron will have an option to commercially license the Xeris technology for such molecules and nominate additional molecules for reformulation and potential commercialization. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

April 05, 2023 01:18 PM Eastern Daylight Time

Video
Article thumbnail News Release

HealthLynked discusses year-end financials and MedOfficeDirect prospects in development

HealthLynked

HealthLynked chairman and CEO Dr Michael Dent and chief financial officer George O'Leary join Proactive's Natalie Stoberman to share highlights from the company's fourth-quarter and full-year 2022 financial results. HealthLynked reported revenue of $5.86 million, a 10% decrease compared to $6.50 million in 2021. Dent says the decline is primarily attributed to decreases in patient service revenue at the Naples Women’s Center and Bridging the Gap facilities, as well as lower product revenue from MedOfficeDirect. However, the company has reported that the decrease was partially offset by revenue increases at its Naples Center for Functional Medicine facility and revenue from the newly-acquired Aesthetics Enhancements Unlimited practice. Contact Details Proactive Investors +1 347-449-0879 na-editorial@proactiveinvestors.com

April 05, 2023 01:13 PM Eastern Daylight Time

Video
Article thumbnail News Release

Algernon NeuroScience reports successful second cohort dosing in DMT clinical study

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals CEO Christopher Moreau joined Steve Darling from Proactive to share news the company’s subsidiary Algernon Neuroscience has completed dosing of the second cohort in the Phase 1 clinical study of DMT. Moreau tells Proactive the study is to identify the safety and tolerability of DMT when administered as an intravenous bolus followed by a prolonged infusion of 6 hours which has never been studied clinically. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 05, 2023 01:03 PM Eastern Daylight Time

Video
Article thumbnail News Release

BioHarvest Sciences announces launch of “Real Stories” media campaign for VINIA red grape supplement

BioHarvest Sciences Inc.

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share news the company will be launching a major media campaign to support its flagship supplement VINIA in the United States. Sobel tells Proactive the campaign will use real VINIA users telling their ‘Real Stories” on television and social media. The science behind the product will also be highlighted. BioHarvest has set its 2023 guidance with plans to increase global VINIA sales to over US$17 million. Contact Details Proactive Investors +1 604-688-8158 na-editorial@proactiveinvestors.com

April 05, 2023 12:25 PM Eastern Daylight Time

Video
Article thumbnail News Release

AmeriLife Strengthens Wealth Distribution Leadership to Help Unleash the Power of Its Holistic Platform

AmeriLife

AmeriLife Group, LLC (“AmeriLife”), a national leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions, today announced the next phase of changes to its Wealth organization, which are aimed at redefining the independent agent and advisor experience and breaking through traditional distribution models. Effective immediately, TruChoice Financial Group President and CEO Brian Peterson will assume expanded responsibilities as president of Accumulation and Retirement Income Distribution. Peterson, whose focus will be on growing annuity sales across the AmeriLife enterprise, will also help lead a significant effort to bring to market a world-class, integrated Wealth platform that delivers on AmeriLife’s client-centric, holistic approach. Peterson will have direct oversight over the performance of AmeriLife’s annuities-focused affiliates, in addition to TruChoice, as part of his new responsibilities. “Brian’s leadership is well known throughout our industry, and was a key reason why AmeriLife was so excited to add TruChoice to its family of companies,” said Mike Vietri, Chief Distribution Officer of AmeriLife’s Wealth Distribution. “Today, it’s a pleasure to welcome him again in a new capacity in which he’ll help shape and lead the direction of our accumulation and retirement income efforts; maximize the potential of our annuities-focused companies and their advisors; and help drive new, innovative solutions for their clients.” “I’m thrilled to work with AmeriLife in this expanded role, but even more excited for the opportunities that lie ahead for our growing distribution network,” added Peterson. “Our advisors are helping their clients navigate through extraordinary economic times. I believe that, together, we can ensure that they have the platforms, resources and solutions they need to meet and exceed their clients’ challenges. I look forward to getting to work to deliver on that promise.” Peterson’s appointment follows AmeriLife’s recent restructuring of the company’s Distribution organization, during which it created distinct Wealth and Health groups to better meet the growing demands of the market, AmeriLife’s affiliated companies, and their agents and advisors. These efforts continue as AmeriLife’s Wealth Distribution continues to fortify its ranks to better leverage recent strategic acquisitions (such as TruChoice) and maximize existing partnerships and the industry-leading offerings of Saybrus Partners, Brookstone Capital Management and ICON, AmeriLife’s joint venture with AIMCOR Group. Denny Southern, previously president of Annuities and Retirement Planning, will assume a new role leveraging his carrier-side experience, industry relationships and deep product expertise to — in collaboration with Peterson and other Wealth leaders — support product innovation for the Wealth platform. “AmeriLife’s Wealth Distribution aims to empower agents and advisors who demand more out of their independent distribution platforms, as well as become the partner of choice to make sure their clients, no matter their stages of life, never outgrow them,” said Vietri. “Our holistic approach brings together three core pillars — Accumulation and Retirement Income, Protection Income and Advisory Services — that are essential to delivering the peace of mind that today’s retirees need to live longer, healthier and happier lives. Today’s announcement is simply the next step to deliver on that promise.” ### About AmeriLife AmeriLife’s strength is its mission: to provide insurance and retirement solutions to help people live longer, healthier lives. In doing so, AmeriLife has become recognized as the leader in developing, marketing, and distributing life and health insurance, annuities and retirement planning solutions to enhance the lives of pre-retirees and retirees across the United States. For more than 50 years, AmeriLife has partnered with top insurance carriers to provide value and quality to customers served through a distribution network of over 300,000 insurance agents and advisors and 120 marketing organizations and insurance agency locations nationwide. For more information, visit AmeriLife.com, and follow AmeriLife on Facebook and LinkedIn. Contact Details Media Jeff Maldonado +1 321-297-1112 jmaldonado@amerilife.com Partnership Inquiries Patrick Nichols +1 727-726-0726 pnichols@amerilife.com Company Website https://amerilife.com/

April 05, 2023 09:30 AM Eastern Daylight Time

Article thumbnail News Release

Software Effective Solutions "MEDCANA" (OTC: SFWJ) Provides Corporate Update for Shareholders

Software Effective Solutions Corp.

McapMediaWire -- Software Effective Solutions, (OTC: SFWJ ) (“The Company”, “SFWJ”) dba MedCana is a global holding company focused on acquiring and developing companies in the cannabis industry with initial focus in Central and South America. In late 2021, Software Effective Solutions Corp. dba MedCana acquired five companies with licenses to produce, process, and export cannabis with and without T.H.C. The purchased companies have a combined total area of 105 Acres (42.84 Hectares). MedCana has also secured the option to expand operations to an additional 177 Acres (72 Hectares) as needed. The primary area of operation is outside of Marinilla, a small town approximately one hour away from Medellin in the department of Antioquia, Colombia. Initial design as well as all environmental, geological, and hydrological have been completed and the project will be ready to break ground in June of 2023. In September 2022, MedCana also acquired Tokan Corp’s assets, a software company, with the focus of creating an ERP platform for the cannabis industry to track the seed to patient process. In October of 2022, MedCana acquired Eko2O S.A.S. a company focused on design and distribution of greenhouses and advanced irrigation platforms. The track record, experience, and industry knowledge that CEO Juan Ricardo Velez brings has set the company up for explosive growth in the region while also dramatically decreasing costs for MedCana’s subsidiaries in the region. SFWJ CEO Gabriel Diaz states, "We are extremely pleased with the progress we've made in the past several months. We look forward to updating shareholders, and are committed to doing everything possible to increase shareholder value." ABOUT SFWJ: Software Effective Solutions/MedCana is a global infrastructure and holding company in the cannabis industry. Currently, MedCana has five companies focused on pharmaceutical cannabis production, one software company focused on managing processes for plant-to-patient operations. The recent acquisition an irrigation and greenhouse technology company has rounded out MedCana’s portfolio of companies. MedCana's initial focus is on developing clients and companies in Latin America with an initial focus in Colombia and partnerships with laboratories, research facilities, and hospitals throughout the world. SAFE HARBOR STATEMENT This press release contains forward-looking statements that can be identified by terminology such as "believes," "expects," "potential," "plans," "suggests," "may," "should," "could," "intends," or similar expressions. Many forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results to be materially different from any future results implied by such statements. These factors include, but are not limited to, our ability to continue to enhance our products and systems to address industry changes, our ability to expand our customer base and retain existing customers, our ability to effectively compete in our market segment, the lack of public information on our company, our ability to raise sufficient capital to fund our business, operations, our ability to continue as a going concern, and a limited public market for our common stock, among other risks. Many factors are difficult to predict accurately and are generally beyond the company's control. Forward-looking statements speak only as to the date they are made, and we do not undertake to update forward-looking statements to reflect circumstances or events that occur after the date the forward-looking statements are made. Contact: Jose Gabriel Diaz, CEO www.medcana.net info@medcana.co Contact Details MedCana info@medcana.co Company Website https://www.medcana.net/

April 05, 2023 09:00 AM Eastern Daylight Time

1 ... 134135136137138 ... 298